Summary
The Israeli study examines breakthrough infections in immunocompromised individuals following full vaccination with the Pfizer-BioNTech COVID-19 vaccine. The research reveals that despite full vaccination, immunocompromised patients exhibit a higher incidence of breakthrough infections compared to the general population. The study underscores the need for additional protective measures and potentially booster doses for this vulnerable group to enhance immunity and reduce the risk of severe outcomes.